{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/49281-126#drug","name":"FLUZONE HIGH DOSE NORTHERN HEMISPHERE","alternateName":"INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"49281-126"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA103914"}],"activeIngredient":"INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)","administrationRoute":["INTRAMUSCULAR"],"dosageForm":"INJECTION, SUSPENSION","manufacturer":{"@type":"Organization","name":"Sanofi Vaccines US Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"VACCINE","sameAs":["https://api.morvs.ai/drug-approval/BLA103914","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49281-126"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T17:41:21.590Z"}}